Home › Products › Infectious Disease › Mydacla 60mg Tablet
Mydacla 60mg Tablet
Salt Composition: DACLATASVIR
- Manufacturer: MYLAN PHARMACEUTICALS PVT LTD
- Pack Size: 28 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 60MG
- Prescription Required
- Storage: Store at room temperature (20°C and 25°C). Protect the medicine from light and excessive moisture. Keep the medicine out of reach of children and pets If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
₹3938.00₹5625.00
Inclusive of all taxes
Product Introduction
Mydacla 60mg Tablet contains the active ingredient Daclatasvir. It is an antiviral medicine belonging to the group of hepatitis C virus (HCV) NS5A inhibitors. It is used together with another medication to treat chronic hepatitis C (an ongoing viral infection that damages the liver). It works by preventing the virus that causes hepatitis C from spreading within the body.
Do not take Mydacla 60mg Tablet if you are allergic to Daclatasvir or any other ingredients in this medicine. This medicine must always be used in combination with other medicines for hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before starting treatment. Report to your doctor if you experience shortness of breath, lightheadedness, palpitations, or fainting while taking this medicine.
Mydacla 60mg Tablet is not recommended for patients below 18 years of age. Do not take this medicine if you are pregnant or breastfeeding. Use effective contraception during treatment.
The common side effects of this medicine are headache, tiredness, anaemia, and nausea.
Uses
Chronic hepatitis C virus
How it works
This medicine works by stopping the hepatitis C virus from multiplying and infecting new cells. This lowers the amount of hepatitis C virus in your body and removes the virus from your blood over a period of time.
How to Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of mydacla 60mg tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Decreased heart rate Liver failure Reactivation of hepatitis B virus Common Nausea Headache Tiredness Dizziness
Expert Tips
Take all of the medicine and complete the course of therapy even if you feel better after the first few doses. Do not take extra doses or medicine to make up for a missed dose. Avoid pregnancy during combination treatment with daclatasvir, sofosbuvir, and ribavirin for 6 months of stopping treatment. Tell your doctor right away if you or your partner becomes pregnant. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
References
- Daclatasvir - Summary Of Product Characteristics; Revised 2020. Accessed May 16, 2023. https://www.ema.europa.eu/en/documents/product-information/daklinza-epar-product-information_en.pdf
- Daclatasvir - Highlights of Prescribing Information; Revised 2017. Accessed May 16, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206843s006lbl.pdf
- Yash Gandhi et al; Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics; Clinical Pharmacokinetics; Published on Aug 2018; Accessed May 16, 2023; https://pubmed.ncbi.nlm.nih.gov/29353349/
- Gillian M Keating; Daclatasvir: A Review in Chronic Hepatitis C; Drugs; Published on Sept 2016; Accessed May 16, 2023; https://pubmed.ncbi.nlm.nih.gov/27550544/
Safety Advice
Pregnancy: unsafe Do not take mydacla 60mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during and for 5 weeks after your last dose.
Lungs: Consult your doctor It is unknown whether mydacla 60mg tablet is safe to be administered in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking mydacla 60mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.